期刊
JAMA NETWORK OPEN
卷 5, 期 9, 页码 -出版社
AMER MEDICAL ASSOC
DOI: 10.1001/jamanetworkopen.2022.30637
关键词
-
资金
- Fundacao Amazonia de Amparo a Estudos e Pesquisa [FAPESPA 006/2020]
- Secretaria de Estado de Ciencia, Tecnologia e Educacao Tecnica e Tecnologica [SECTET 09/2021]
- Coordination for the improvement of Higher Education Personnel (CAPES PDPG AMAZONIA LEGAL)
Determining the characteristics, type, and severity of olfactory dysfunction in patients with long COVID is crucial. This study aimed to describe the socio-demographic and clinical features of patients with persistent olfactory dysfunction. The results showed that olfactory dysfunction is one of the most common long-term neurological symptoms of COVID-19, and patients with this condition may experience severe hyposmia or anosmia for more than 1 year from the onset of symptoms.
IMPORTANCE Determining the characteristics, type, and severity of olfactory dysfunction in patients with long COVID is important for the prognosis and potential treatment of the affected population. OBJECTIVE To describe the sociodemographic and clinical features of patients with long COVID who develop persistent olfactory dysfunction. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study, conducted at a rehabilitation center at a public university in the Amazon region of Brazil between September 9, 2020, and October 20, 2021, comprised 219 patients with long COVID and self-reported neurologic symptoms. Of these 219 patients, 139 received a diagnosis of chronic olfactory dysfunction, as confirmed by the Connecticut Chemosensory Clinical Research Center (CCCRC) test. EXPOSURE Clinical diagnosis of long COVID. MAIN OUTCOMES AND MEASURES Electronic case report forms were prepared for the collection of sociodemographic and clinical data. Patients' sense of smell was evaluated via a CCCRC test, and the association of olfactory dysfunction with aspects of daily life was recorded using a questionnaire. RESULTS Of the 219 patients included in the study, 164 (74.9%) were women, 194 (88.6%) were between 18 and 59 years of age (mean [SD] age, 43.2 [12.9] years), 206 (94.1%) had more than 9 years of education, and 115 (52.5%) had a monthly income of up to US $192.00. In the study group, 139 patients (63.5%) had some degree of olfactory dysfunction, whereas 80 patients (36.5%) had normosmia. Patients with olfactory dysfunction had a significantly longer duration of long COVID symptoms than those in the normosmia group (mean [SD], 242.7 [101.9] vs 221.0 [97.5] days; P=.01). Among patients with anosmia, there was a significant association between olfactory dysfunction and daily activities, especially in terms of impairment in hazard detection (21 of 31 patients [67.7%]), personal hygiene (21 of 31 patients [67.7%]), and food intake (21 of 31 patients [67.7%]). Univariable logistic regression analyses found that ageusia symptoms were associated with the occurrence of olfactory dysfunction (odds ratio [OR], 11.14 [95% CI, 4.76-26.07]; P<.001),whereas headache (OR, 0.41 [95% CI, 0.22-0.76]; P<.001) and sleep disorders (OR, 0.48 [95% CI, 0.26-0.92]; P=.02) showed an inverse association with the occurrence of olfactory dysfunction. CONCLUSIONS AND RELEVANCE Olfactory dysfunction is one of the most important long-term neurologic symptoms of COVID-19, with the highest prevalence seen among women, adults, and outpatients. Patients with olfactory dysfunction may experience persistent severe hyposmia or anosmia more than 1 year from the onset of symptoms, suggesting the possibility of the condition becoming a permanent sequela.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据